Glucocorticoid therapy does not delay viral clearance in COVID-19 patients.

Ji, Jingjing; Zhang, Jinxia; Shao, Ziyun; Xie, Qifeng; Zhong, Li; Liu, Zhifeng

Ji, Jingjing; Zhang, Jinxia; Shao, Ziyun; Xie, Qifeng; Zhong, Li; Liu, Zhifeng.

Ji J; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China.
Zhang J; Cardiovascular Department, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China.
Shao Z; Department of Nephrology, General Hospital of Central Theater Command of PLA, Wuhan, 430070, China.
Xie Q; Department of Urology Surgery, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China.
Zhong L; Department of Critical Care Medicine, The First Affiliated Hospital, Guizhou University of Chinese Medicine, Guiyang, 550001, China.
Liu Z; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China. Zhifengliu7797@163.com.

Crit Care ; 24(1): 565, 2020 09 21.

Article in English | MEDLINE | ID: covidwho-781514

Subject(s)

Glucocorticoids/therapeutic use; Betacoronavirus/genetics; Betacoronavirus/isolation & purification; Cohort Studies; Coronavirus Infections/drug therapy; Humans; RNA, Viral/blood; SARS-CoV-2; Treatment Outcome; COVID-19 Drug Treatment

Keywords

COVID-19; Glucocorticoid; Viral clearance

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Glucocorticoids Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Crit Care Year: 2020 Document Type: Article Affiliation country: S13054-020-03287-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google